Cervical precancer treatment study for women with HIV
Part of Cancer, Immune system & allergy, Infections, Women’s health & pregnancy clinical trials.
This study tests whether using one or two heat probes works better to remove cervical precancer in women with HIV. Participants will get treatment at a clinic in Rwanda and be checked again after 6 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between the ages of 25 and 49.
- You are living with HIV.
- You have not had a hysterectomy (your cervix is intact).
- You have a positive test for high-risk HPV or a visual inspection (VIA) result within the last 3 months.
- You are willing to return to the clinic 6 months after treatment.
- You are not pregnant and it has been at least 6 weeks since you gave birth.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares using one versus two probes during a heat treatment (thermal ablation) for early cervical changes in women living with HIV. The goal is to see which approach is more feasible and effective, hopefully preventing cervical cancer.
This study tests whether using one or two heat probes is better at removing precancerous cells from the cervix in women living with HIV. It aims to find a simpler, more effective way to prevent cervical cancer.
This study tests whether using one or two heat probes is better at removing precancerous cells from the cervix in women living with HIV. It aims to find a simpler, effective way to treat cervical precancer and prevent cancer.
This trial tests a new way to quickly diagnose and treat cervical pre-cancer using a point-of-care device. It may help women who are HPV-positive avoid a separate treatment visit.
This study looks at how well the HPV vaccine works in women living with HIV and whether it helps make cervical cancer screening more accurate. If you are a woman with HIV between 21 and 40 years old and already part of certain other HIV studies, you may be able to join.
This study looks at ways to improve cervical cancer screening and follow-up for women with HIV. If you are a woman with HIV aged 25 or older, this research may help understand how to make screening easier and more available.
Hear when a new HIV (Human Immunodeficiency Virus) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.